Sort
46,585 grants matching “heart failure”
Rare variants and NHLBI traits in deeply phenotyped cohorts
$685,818Bruce M Psaty · University Of Washington · R01 · FY2015 · HL
Determinants, Trajectories, and Consequences of Abnormal Cardiac Mechanics
$685,801Sanjiv J Shah · Northwestern University At Chicago · R01 · FY2018 · HL
Deciphering the role of a circadian lncRNA in cardiac remodeling
$685,778Lilei Zhang · Baylor College Of Medicine · R01 · FY2025 · HL
Cognitive Benefits of Cardiac Rehabilitation in Heart Failure
$685,759John J Gunstad · Kent State University · R01 · FY2010 · HL
Role of Mitochondrial Health in Acute and Chronic Kidney Disease in Older Adults
$685,746Michael G Shlipak · Northern California Institute/Res/Edu · R01 · FY2021 · AG
Improving Kidney Function Assessment in Health and Disease
$685,739Lesley Ann Inker · Tufts Medical Center · R01 · FY2024 · DK
Quantifying cardiac structure and function to define the progression to hear failure in African Americans
$685,735Amil M Shah · Brigham And Women'S Hospital · R01 · FY2021 · HL
Network Medicine and Systems Pharmacology to Advance Precision Medicine in Combined Pulmonary Hypertension
$685,723Evan L Brittain · Vanderbilt University Medical Center · R01 · FY2024 · HL
Renin cell identity and blood pressure homeostasis
$685,695Maria L Sequeira Lopez · University Of Virginia · R01 · FY2020 · HL
Structural Studies of Ion Channel Assembly and Signaling Complexes
$685,689Daniel L Minor · University Of California, San Francisco · R01 · FY2024 · DC
The mechanisms and roles of mitochondria dysfunction in cardiac arrhythmogenesis
$685,631Dmitry A Terentyev · Ohio State University · R01 · FY2025 · HL
Characterization of Molecular and Physiologic Signatures of Impaired Multi-Organ System Reserve Capacity During Exercise in Heart Failure with Preserved Ejection Fraction
$685,596Gregory Dyer Lewis · Massachusetts General Hospital · R01 · FY2020 · HL
Cardiovascular Research Program
$685,500Donald M Bers · University Of California At Davis · P30 · FY2009 · HL
Prophylactic Intra-Operative VT Ablation in High-Risk LVAD Candidates
$685,498David T Huang · University Of Rochester · R01 · FY2025 · HL
REHAB-PH Trial: Repurposing a Histamine Antagonist to Benefit Patients with Pulmonary Hypertension
$685,472Peter J Leary · University Of Washington · R61 · FY2018 · HL
Development of a Pediatric Total Artificial Heart
$685,390William J Weiss · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2018 · HL
SGLT-inhibitors in patients with hypertrophic cardiomyopathy
$685,334Sharlene M Day · University Of Pennsylvania · R33 · FY2025 · HL
PBK: A novel mediator of VSMC proliferation and vascular remodeling in PAH
$685,300David J Fulton · Augusta University · R01 · FY2021 · HL
Chip phosphorylation stimulates the degradation of mutant transthyretin to attenuate cardiac amyloidosis
$685,249Mark John Ranek · Johns Hopkins University · R01 · FY2025 · HL
Repair and Angiogenesis by Stem Cells in Human Heart
$685,199Piero Anversa · Brigham And Women'S Hospital · R37 · FY2015 · HL
High Shear Stress Alters Gene Regulation in Pulmonary Arterial Hypertension
$685,156Marlene Rabinovitch · Stanford University · R01 · FY2021 · HL
Off-label drugs in cardiology: evaluating age- and disease-appropriate therapies
$685,049Nikki Gillum Posnack · Children'S Research Institute · R01 · FY2022 · HD
Immunologic basis of cardiac disease after severe COVID-19
$685,031Chetan N Shenoy · University Of Minnesota · R01 · FY2023 · HL
Junctophilin-1 in the heart
$684,937Long-Sheng Song · University Of Iowa · R01 · FY2025 · HL
Project 3: Translating Pulmonary Xenotransplantation
$684,928Richard N Pierson · Massachusetts General Hospital · U19 · FY2025 · AI